Buchumschlag

A sequential targeting strategy interrupts AKT-driven subclone-mediated progression in glioblastoma

Therapy resistance and fatal disease progression in glioblastoma are thought to result from the dynamics of intra-tumor heterogeneity. This study aimed at identifying and molecularly targeting tumor cells that can survive, adapt, and subclonally expand under primary therapy.To identify candidate mar...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Kebir, Sied (VerfasserIn) , Herold-Mende, Christel (VerfasserIn) , Scheffler, Björn (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 15 January 2023
In: Clinical cancer research
Year: 2023, Jahrgang: 29, Heft: 2, Pages: 488-500
ISSN:1557-3265
DOI:10.1158/1078-0432.CCR-22-0611
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1158/1078-0432.CCR-22-0611
Verlag, lizenzpflichtig, Volltext: https://aacrjournals.org/clincancerres/article/29/2/488/713980/A-Sequential-Targeting-Strategy-Interrupts-AKT
Volltext
Verfasserangaben:Sied Kebir, Vivien Ullrich, Pia Berger, Celia Dobersalske, Sarah Langer, Laurèl Rauschenbach, Daniel Trageser, Andreas Till, Franziska K. Lorbeer, Anja Wieland, Timo Wilhelm-Buchstab, Ashar Ahmad, Holger Fröhlich, Igor Cima, Shruthi Prasad, Johann Matschke, Verena Jendrossek, Marc Remke, Barbara M. Grüner, Alexander Roesch, Jens T. Siveke, Christel Herold-Mende, Tobias Blau, Kathy Keyvani, Frank K.H. van Landeghem, Torsten Pietsch, Jörg Felsberg, Guido Reifenberger, Michael Weller, Ulrich Sure, Oliver Brüstle, Matthias Simon, Martin Glas, and Björn Scheffler
Beschreibung
Zusammenfassung:Therapy resistance and fatal disease progression in glioblastoma are thought to result from the dynamics of intra-tumor heterogeneity. This study aimed at identifying and molecularly targeting tumor cells that can survive, adapt, and subclonally expand under primary therapy.To identify candidate markers and to experimentally access dynamics of subclonal progression in glioblastoma, we established a discovery cohort of paired vital cell samples obtained before and after primary therapy.
Beschreibung:Online veröffentlicht am 14. Oktober 2022
Gesehen am 28.11.2023
Beschreibung:Online Resource
ISSN:1557-3265
DOI:10.1158/1078-0432.CCR-22-0611

Ähnliche Einträge